Clinical trial registry record

Clostridioides Difficile and Frailty

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated August 18, 2023.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT05447533
Last registry update
August 18, 2023
Status
Completed
Phase
Phase not reported
Sponsor
University of Aarhus
Enrollment
217
Countries
Denmark
Match confidence
80%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
RANDOMIZED · PARALLEL · SUPPORTIVE CARE · SINGLE
Evidence population
Human clinical study registration
Participants
217
Population
ALL · 70 Years
Duration
2022-09-16 to 2023-08-16
Intervention
Comprehensive geriatric assessment (CGA); Continued geriatric care; Faecal microbiota transplantation (FMT); Standard care
Comparator
Standard care
Outcomes measured
90-day mortality — Date of 90-day follow-up will include day of positive PCR test for CD and day 90 from date of positi…; Physical functional status — 83-97 weekdays after date of positive PCR test for Clostridioides difficile.; Overall quality of life assessed by Depression List — 83-97 weekdays after date of positive PCR test for Clostridioides…; Quality of life assessed by the 5-level EQ-5D Interviewer version — 83-97 weekdays after date of positive PCR test for…; Quality of life assessed by the 5-level EQ-5D proxy 2 version — 83-97 weekdays after date of positive PCR test for Clos…
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 80% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Frailty · 80%Title contains controlled topic terminology. Title supplies ageing or longevity context.

Automated source check 100% · update recency 50%. These figures help sort records; they are not medical ratings.

frailty
Read the original source →Export JSON